State SD
Clinical Trials in South Dakota
Recruiting clinical trials with at least one study location in South Dakota. Data updated daily from ClinicalTrials.gov.
Top Conditions in South Dakota
Heart Failure (2)Lung Non-Small Cell Carcinoma (2)Stage II Lung Cancer AJCC v8 (2)Stage IIIA Lung Cancer AJCC v8 (2)Stage IIIB Lung Cancer AJCC v8 (2)Anatomic Stage IV Breast Cancer AJCC v8 (2)Breast Cancer (2)Stage IV Nasopharyngeal Carcinoma AJCC v8 (2)Anatomic Stage I Breast Cancer AJCC v8 (1)Anatomic Stage II Breast Cancer AJCC v8 (1)Anatomic Stage IIIA Breast Cancer AJCC v8 (1)Anatomic Stage IIIB Breast Cancer AJCC v8 (1)
Frequently Asked Questions — Clinical Trials in South Dakota
How many clinical trials are currently recruiting in South Dakota?
ClinicalMetric currently tracks 43 actively recruiting clinical trials with at least one location in South Dakota. The total number of registered studies—including active but not currently enrolling trials—is 43. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in South Dakota?
South Dakota hosts clinical trials across a broad range of medical conditions, including Heart Failure, Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout South Dakota serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in South Dakota?
To join a clinical trial in South Dakota, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in South Dakota maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in South Dakota
NCT05929768 Phase 3
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple N...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
2,400 pts
Location
United States, Mexico, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06589804 Phase 3
Recruiting
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatme...
Condition
Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment
158 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05064709 N/A
Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Condition
Heart Failure
Enrollment
1,500 pts
Location
United States
Sponsor
Impulse Dynamics
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT07223840 Phase 2
Recruiting
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid R...
Condition
Smoking
Enrollment
222 pts
Location
United States, China, Japan
Sponsor
Eli Lilly and Company
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03998202 N/A
Recruiting
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal...
Condition
Colorectal Cancer
Enrollment
300 pts
Location
United States
Sponsor
Wake Forest University Health
NCT03851445 Phase 2, Phase 3
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung...
Condition
Previously Treated Non-Small Cell Lung Cancer
Enrollment
10,000 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04031677 Phase 3
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sa...
Condition
Retroperitoneal Sarcoma
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
European Organisation for Rese
NCT06619561 Phase 2
Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host ...
Condition
Chronic Graft-Versus-Host Disease (cGVHD)
Enrollment
48 pts
Location
United States
Sponsor
Deciphera Pharmaceuticals, LLC
NCT04614103 Phase 2
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Condition
Metastatic Non Small Cell Lung Cancer
Enrollment
170 pts
Location
United States, Australia, Canada
Sponsor
Iovance Biotherapeutics, Inc.
NCT06700460 N/A
Recruiting
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
Condition
Myopia
Enrollment
56 pts
Location
United States
Sponsor
Vance Thompson Vision
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05848739 Phase 1
Recruiting
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tu...
Condition
Colon Cancer
Enrollment
130 pts
Location
United States
Sponsor
Sapience Therapeutics
NCT07221357 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Che...
Condition
Untreated, Unresectable, or Metastatic Colorectal Cancer
Enrollment
990 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06935370 Phase 3
Recruiting
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozi...
Condition
Heart Failure
Enrollment
4,200 pts
Location
United States, Argentina, Belgium
Sponsor
Boehringer Ingelheim
NCT06084936 Phase 3
Recruiting
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Pa...
Condition
Lymphoma
Enrollment
182 pts
Location
United States, Australia, Brazil
Sponsor
Hoffmann-La Roche
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT05702645 N/A
Recruiting
A Study to Learn More About the Health of Persons With Down Syndrome After Treat...
Condition
B Acute Lymphoblastic Leukemia Associated With Down Syndrome
Enrollment
330 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT05952557 Phase 3
Recruiting
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2-...
Condition
Breast Cancer, Early Breast Cancer
Enrollment
5,500 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06163534 N/A
Recruiting
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
Tempus AI
NCT06492616 Phase 3
Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With E...
Condition
Breast Cancer
Enrollment
4,220 pts
Location
United States, Argentina, Australia
Sponsor
Stemline Therapeutics, Inc.
NCT07219966 Phase 3
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disor...
Condition
Alcohol Use Disorder
Enrollment
1,100 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company
NCT07221253 Phase 3
Recruiting
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatmen...
Condition
Biliary Tract Cancer
Enrollment
1,100 pts
Location
United States, Australia, Belgium
Sponsor
AstraZeneca
NCT06112613 N/A
Recruiting
Mobile Health for Adherence in Breast Cancer Patients
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
410 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
Page 1 of 2 — 43 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology